Subtle Medical Announces Strong 2025 Growth, Expands Market Leadership in AI Imaging

MENLO PARK, Calif., Oct. 1, 2025 /PRNewswire/ -- Subtle Medical, a global leader in AI-powered medical imaging, today announced major growth milestones, projecting 2.5x annualized revenue growth in the U.S. for 2025, fueled by strong enterprise demand and new product introductions. Their U.S. adoption now spans more than 600 installations and well over 1000 globally.

Subtle continues to lead the AI imaging enhancement market, with multiple FDA-cleared solutions and the broadest install base among competitors. Its flagship SubtleHD™ software and newly launched Subtle-ELITE™ suite are enabling health systems to accelerate scans, improve image quality, and optimize workflow efficiency.

Last week, TIME recognized Subtle Medical on its list of the World's Top HealthTech Companies of 2025, highlighting the company's impact in AI and data-driven innovation for imaging.  Leading providers are deepening their enterprise-level partnerships with Subtle, citing measurable ROI and improved patient care.

"Subtle's technology delivers value across our MRI operations.  As such, RadNet is able to accelerate scans while maintaining diagnostic confidence and reducing patient burden. The collaboration ensures our patients and physicians benefit from some of the best innovations in the field," said Steven Forthuber, President & Chief Operating Officer, Eastern Operations, RadNet.

"SimonMed's selection of Subtle as a collaboration partner pushes forth our mission to advance precision diagnostic imaging with AI, to improve the patient MRI experience and to allow us to continue to provide AI-enhanced care in an affordable and accessible way," said John Simon, MD, Founder & CEO, SimonMed Imaging.

"Subtle's technology is already delivering value across our MRI operations," said Jin Kim, MD, CEO of Rezolut. "It enables us to accelerate scans while maintaining diagnostic confidence, reducing patient burden, and improving overall image quality. We are excited to expand our use of this innovative technology across our centers."

The company's expansion is fueled by recent FDA clearances, OEM partnerships, and enterprise customer expansions. Solutions such as SubtleSYNTH™, the only FDA-cleared AI solution for synthetic imaging, and AiMIFY™, a first-of-its-kind AI solution for enhanced contrast developed with Bracco, extend Subtle's portfolio across MR, PET, and CT.

"Subtle's growth trajectory demonstrates both the strength of our technology and the trust our customers place in us," said Enhao Gong, PhD, Cofounder & CEO of Subtle Medical. "We are proud to lead the industry in building AI that accelerates, enhances, and organizes imaging data across modalities to deliver better care at scale."

Validated results from Subtle customers includes the ability to:

• Enhance up to 80% faster scans and 50%+ higher throughput
• Improve diagnostic confidence through enhanced image quality
• Increase scanner utilization and extend equipment lifespan
• Achieve SaaS scalability across large imaging networks

With record adoption, validated ROI, and unmatched regulatory clearances, Subtle Medical is advancing its multi-modal strategy to further accelerate, enhance, and organize imaging data. Its mission remains clear: to empower healthcare providers with scalable AI solutions that improve quality, efficiency, and patient outcomes worldwide. Meet with us at RSNA 2025.

About Subtle Medical

Subtle Medical is a leading provider of AI-powered imaging solutions, optimizing scanner efficiency and image quality across radiology. Recognized by TIME on its World's Top HealthTech Companies of 2025 list and multiple times by CB Insights as a GenAI 50, Digital Health 150, and Top AI 100 company, Subtle Medical is committed to transforming medical imaging through intelligent software solutions. The company's products are deployed on over 1000 scanners worldwide, helping imaging centers and hospitals deliver faster scans, improved image quality, and better patient care, without the need for new hardware. Learn more at www.subtlemedical.com.

Media Contact:
Anna Menyhart-Borroni
Head of Global Marketing
[email protected]

SOURCE Subtle Medical, Inc.